Genizon BioSciences

company

About

Genizon Biosciences discovers genes and biomarkers in common diseases using genome-wide association studies.

  • 1 - 10

Details

Last Funding Type
Series Unknown
Last Funding Money Raised
$16.50M
Industries
Biotechnology,Genetics,Life Science,Medical Device
Founded date
Jan 1, 1999
Number Of Employee
1 - 10
Operating Status
Active

Genizon Biosciences Inc. discovers genes and biomarkers in common diseases using genome wide association studies (GWAS), leveraging its proven and proprietary technology platform and access to patients from the Quebec Founder Population.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
7
$67.01M $32.25M
Genizon BioSciences has raised a total of $67.01M $32.25M in funding over 2 rounds. Their latest funding was raised on Jan 1, 2008 from a Series E round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jan 1, 2008 Series E $30.81M 2 Biotech Turnaround Fund (BTF) Detail
Feb 5, 2007 Series D $10M 1 Detail
Mar 29, 2006 Series Unknown $12M 2 Detail
Dec 13, 2004 Series B $11.10M 1 Detail
Jan 7, 2004 Series Unknown $11.15M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
4
Genizon BioSciences is funded by 4 investors. Biotech Turnaround Fund (BTF) and Investissement Desjardins are the most recent investors.
Investor Name Lead Investor Funding Round
Biotech Turnaround Fund (BTF) Yes Series E
Investissement Desjardins Series E
MVI Finance Series Unknown
Biofund Series Unknown